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http://dx.doi.org/10.1016/j.hkjn.201Summary Background/Purpose: Abnormality in cardiac structure and function is common in
chronic kidney disease (CKD) patients. We aimed to evaluate the prevalence of different
abnormal echocardiographic findings in CKD patients and find their associated factors.
Methods: This retrospective cross-sectional study was conducted in the Nephrology and Dial-
ysis Department of the Shiraz University of Medical Sciences. A total number of 1354 kidney
transplant candidates between the years 2000 and 2010 were included. Association between
variables was assessed by Chi-square test and Student t test. We analyzed our data using multi-
variate logistic and linear regression when appropriate.
Results: Left ventricular hypertrophy (LVH; 47.5%) was the most common finding in this study,
followed by left atrial enlargement (43.7%), diastolic dysfunction (25.4%), left ventricular end
diastolic dilation (23.1%), and systolic dysfunction (18.5%), in order of frequency. Older age
was associated with abnormality in all echocardiographic indexes. Male gender was associated
with LVH and systolic dysfunction. We found an association between a longer duration since
CKD diagnosis and LVH. Left ventricular end diastolic dilation, left atrial enlargement, and dia-
stolic dysfunction were associated with a longer duration of dialysis. Anemia was associated
with all echocardiographic abnormalities except diastolic dysfunction. Hypoalbuminemia and
hypocalcemia were associated with only left atrial enlargement and left ventricular end dia-
stolic dilation, respectively. Patients on peritoneal dialysis had a lower prevalence of left atrial
enlargement and left ventricular end diastolic dilation.Department, Cardiovascular Research Center, Shiraz University of Medical Sciences, Zand Street,
0.
m (M.H. Nikoo).
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Echocardiography findings in dialysis patients 69Conclusion: Different echocardiographic abnormalities, especially LVH, are prevalent among
CKD patients. Traditional risk factors, such as age, diabetes mellitus, and hypertension, and
uremia-related risk factors, such as anemia and hypoalbuminemia, are associated with an in-




間共 1354 位移植候選者，並採用卡方檢定及 Student’s t test 以檢定各變項間的關聯性。
結果：最常見的發現依序有：左心室肥大 (LVH) (47.5%)、左心房擴大 (43.7%)、舒張功能障礙
(25.4%)、左心室舒張末擴張 (23.1%)、及收縮功能障礙 (18.5%)。所有心臟超音波指標的異常均





結論：心臟超音波指標異常特別是 LVH 在 CKD 患者間相當常見，它們的出現與傳統的危險因子
有關，例如年齡、糖尿病、及高血壓；及尿毒症的相關危險因子如貧血及低白蛋白血症。Introduction
Chronic kidney disease (CKD) patients are at high risk of
cardiovascular diseases, which account for about half of
the mortalities in this population.1 Abnormality in cardiac
structure and function detected by echocardiography is
common in CKD patients.2 Increasing evidence exists sup-
porting the essential role of this tool in estimating the
prevalence of primary heart disease in this population and
studying its predisposing factors, prognostic impact, and
the effect of therapeutic interventions.3
Left ventricular (LV) hypertrophy (LVH)4 and systolic
dysfunction5 are frequent findings in CKD patients, and
represent the strongest risk factors for death and adverse
CV outcomes in this population. LV diastolic function is also
reduced in this population.6
Abnormal filling of the left ventricle and mitral regur-
gitation also result in an increase in the left atrial size,
which also has a prognostic implication.7
In this retrospective cross-sectional study, we aimed to
evaluate the prevalence of different abnormal echocar-
diographic findings in 1354 CKD patients undergoing renal
replacement therapy and find their clinical associations.Methods
This retrospective cross-sectional study was conducted in
the Nephrology and Dialysis Department of Medical Uni-
versity of Shiraz, Iran. Study design was approved by the
Research Ethics Committee of Shiraz University of Medical
Sciences. Kidney transplant candidates had undergone
echocardiographic assessment as a routine pretransplant
evaluation in this department between the years 2000 and
2010. The inclusion criterion was patients aged 18e60 years
old, on hemodialysis (HD) for at least 3 months, who were
candidates for transplant. Patients with congenital and
rheumatic heart disease were excluded.
Demographic, clinical (duration of dialysis and the pri-
mary cause of CKD), and biochemical (hemoglobin, serumalbumin, calcium, and phosphorus) data of these patients in
addition to their echocardiographic reports were extracted
from their medical records and profiles available in the hos-
pital information support system. The echocardiographic
and biochemical data are maximally 3 months apart. All
echoes were performed within a few hours of HD. Patients
underwent two-dimensional, color Doppler, and M-mode
echocardiographic evaluation. The following echocardio-
graphic definitionswereused. LVHwasdefinedas septal and/
or posterior wall thickness 11 mm in males and 10 mm in
females. LV end diastolic diameter more than 54 mm in fe-
males andmore than 59mm inmales and left atrial diameter
more than 39 mm in females and more than 41 mm in males
were considered abnormal. LVejection fraction less than 55%
was indicative of systolic dysfunction. Diastolic dysfunction
was defined using transmitral inflow pattern.8
Data were analyzed by SPSS version 18.0 (SPSS Inc.,
Chicago, IL, USA). Nominal and categorical variables were
described by absolute frequency (%), and scale variables
were described as mean  standard deviation. Association
between variables was assessed by Chi-square test and
Student t test. Data was analyzed using multivariate logistic
and linear regression when appropriate. A p value of <0.05
was considered significant.
Results
Demographic and clinical data
In this retrospective cross-sectional study, 1354 patients
were included. Themean age of the patients was 38.5 13.7
years, with a male:female ratio of 64.6:35.4. Of these pa-
tients, 11.6% had hypertension, 11.2% were diabetic, and
5.9% had ischemic heart disease. Patientswere ondialysis for
a mean duration of 23.9  22.1 months. They underwent
dialysis from one to three times a week. Vascular access was
performed with arteriovenous fistula in 83% of cases and
double lumen in 17%of cases. Among the 1280 patientswhose
dialysis data were available, 1236 (96.6%) underwent HD and
44 (3.4%) underwent peritoneal dialysis (PD). CKD was
Table 2 Echocardiographic assessment of 1354 chronic




34.38  6.71 97 (7.2)
Left ventricular end
diastolic diameter
52.44  7.13 98 (7.2)
Left atrial diameter 39.07  7.04 159 (11.7)
Left ventricular
septum size
13.19  3.65 137 (8.0)
Ejection fraction 57.14  7.42 109 (8.0)
Left ventricular
hypertrophy




Positive 313 (23.1) 0
Negative 1041 (76.9)
Left atrial enlargement
Positive 592 (43.7) 0
Negative 762 (56.3)
70 M. Pakfetrat et al.diagnosed for a mean duration of 42.8  33.8 months in the
study population. In the study patients, glomerulonephritis,
hypertension, and diabetes mellitus were the most common
etiologies identified for hypertension, diabetes, and
ischemic heart disease, respectively. Table 1 presents de-
mographic, clinical, and biochemical data of the patients
who were included in our study.
Echocardiographic assessment
During echocardiographic evaluation, LVH was found in 643
(47.5%) patients. The left ventricle end diastolic diameter
was above normal in 313 (23.1%) cases. Left atrial enlarge-
ment, systolic dysfunction and diastolic dysfunction were
present in 592 (43.7%) patients, 250 (18.5%) patients, and 344
(25.4%) cases, respectively. Data about echocardiographic
assessment of study population is summarized in Table 2.
Associated factors and echocardiographic
abnormalities
We performed multivariate logistic regression (Table 3),
which showed that the presence of LVH was associated withTable 1 Demographic and clinical data in our study group.
Variables Missing
Age (mean  SD) 38.5  13.7 d
Sex
Male 875 (64.6) d
Female 479 (35.4)
Type of dialysis
Hemodialysis 1307 (96.5) d
Peritoneal dialysis 47 (3.5)
Duration of dialysis 23.9  22.1 d
Duration since diagnosis
of CKD
42.8  33.8 703 (51.9)
Number of sessions during
a week
Once weekly 179 (13.5) d
Twice weekly 763 (56.0)
Three times weekly 412 (30.5)
Hemoglobin (mg/dL) 9.74  2.2 52 (3.8)
Albumin (g/dL) 4.08  0.7 127 (9.4)
Calcium (mg/dL) 8.61  1.2 91 (6.7)
Phosphate (mg/dL) 5.48  2.2 100 (7.4)
Underlying etiology of CKD
Hypertension 157 (11.6)
Diabetes mellitus 152 (11.2)
Glomerulonephritis 249 (18.4)
Kidney stone 78 (5.8)
Cystic kidney disease 78 (5.8)
Obstructive uropathy 18 (1.3)
Reflux nephropathy 23 (1.7)
Pyelonephritis 19 (1.4)
Neurogenic bladder 15 (1.1)
Other disease 18 (1.3)
Unknown 547 (40.4)
Data are presented as n (%) or mean  SD.
CKD Z chronic kidney disease; SD Z standard deviation.
Systolic dysfunction
Positive 250 (18.5) 0
Negative 1104 (81.5)
Diastolic dysfunction
Positive 344 (25.4) 0
Negative 1010 (74.6)
Data are presented as n (%) or mean  SD.age [odds ratio (OR) Z 1.02, p < 0.001], dialysis duration
(ORZ 1.4, p < 0.001), hemoglobin (ORZ 0.9, pZ 0.044),
and albumin (OR Z 0.8, p Z 0.020). Diastolic dysfunction
was associated with age (ORZ 1.1, p < 0.001) and duration
of dialysis (OR Z 1.3, p Z 0.044).
In addition, multivariate linear regression (Table 4)
showed that the LV end diastolic diameter was associated
with age (BZ 0.05, p < 0.007, which means that the LV end
diastolic diameter increases by 0.05 for each year increase
in age), gender (B Z 4.2, male is baseline group;
p Z 0.004), duration since CKD diagnosis (B Z 1.4,
p Z 0.001), hemoglobin (B Z 0.3, p Z 0.003), and cal-
cium (B Z 0.4, p Z 0.04).
Left atrial diameter was associated with age (B Z 0.07,
p < 0.001), gender (B Z 2.1, male is baseline group;
p Z 0.001), duration since CKD diagnosis (B Z 0.03,
pZ 0.011), dialysis duration (BZ 1.4,pZ 0.001), hemoglobin
(BZ0.2,pZ 0.021), and albumin (BZ 0.8, pZ 0.049). In
addition, systolic dysfunctionwas associatedwith only dialysis
duration (BZ 1.4, pZ 0.001), calcium (BZ 0.4, pZ 04).
Finally, our results show that patients on PD had a lower
prevalence of left atrial enlargement and LV end diastolic
dilation. We could not find any similar association in pre-
vious studies.
Discussion
In this retrospective cross-sectional study, we evaluated
the prevalence of different echocardiographic
Table 3 Logistic regression of the association between binary clinical factors and echocardiographic abnormalities in he-
modialysis patients.
Variables Left ventricular hypertrophy Diastolic dysfunction
OR p OR p
Sex
Male 1.00 d 1.00 d
Female 0.03 0.17 0.9 0.525
Type of dialysis
Peritoneal dialysis 1.00 d 1.00 d
Hemodialysis 0.01 0.999 0.01 0.999
Age 1.02 0.001 1.1 0.001
Duration of CKD diagnosis (mo) 1.0 0.923 1.01 0.139
Duration of dialysis (mo) 1.4 0.001 1.3 0.044
Hemoglobin 0.9 0.044 0.9 0.736
Albumin 0.8 0.020 1.1 0.307
Calcium 0.9 0.302 0.9 0.366
Phosphate 1.1 0.084 1.0 0.189
LVH Z left ventricular hypertrophy; OR Z adjusted odds ratio.
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most common finding in this study, followed by left atrial
enlargement (43.7%), diastolic dysfunction (25.4%), LV end
diastolic dilation (23.1%), and systolic dysfunction (18.5%),
in order of frequency. In a study by Foley et al9 in 1995, the
prevalence of echocardiographic abnormalities was evalu-
ated in 433 CKD patients prior to the initiation of dialysis.
On echocardiography, 74% had LVH, 32% had LV dilation,
and 15% had systolic dysfunction. In another study by
Hayashi et al10 in 2006, conventional echocardiography and
tissue Doppler velocity imaging were used to estimate the
prevalence of different echocardiographic abnormalities in
40 CKD patients. LVH and diastolic dysfunction were the
most common findings in this study. Left atrial enlargement
and systolic dysfunction had lower prevalence. To our
knowledge, this study is one of the largest studies that
evaluate simultaneously the prevalence of these five
echocardiographic changes in CKD patients.
Hypertrophy is the common reaction of the heart to
volume and pressure overload in CKD patients similar to
other causes of overload.10 The left atrium enlarges
passively due to increased LV end diastolic pressure
because it tries to fill the left ventricle despite high
impedance.11 LV dilatation needs more time and severity of
volume and pressure overload, and accordingly has a lower
frequency.12 In the beginning, LVH is adaptive; however, it
ultimately becomes maladaptive following myocyte death12
when systolic dysfunction occurs. Thus, systolic dysfunction
can be a terminal event in a hypertrophied heart. Other
pathophysiologic processes such as coronary artery disease,
malnutrition, and hyperparathyroidism can also cause sys-
tolic dysfunction in end stage renal disease (ESRD).13 Dia-
stolic dysfunction in CKD is a result of many
pathophysiologic processes such as hypertension, coronary
artery disease, and chronic uremia.5,8,14
In the second part of this study, we evaluated the as-
sociation between echocardiographic abnormalities and
different clinical factors.
Some of the evaluated factors were traditional risk
factors for cardiovascular disease. Older age was found tobe associated with abnormality in most of the echocardio-
graphic indexes assessed in this study. This association has
consistently been present in previous study.14 Tripepi
et al15 showed that the association between age and some
of these abnormalities is largely dependent on age-related
risk factors such as inflammation, malnutrition, and arterial
rigidity.5,8,15 Male gender was associated with LVH, LV end
diastolic dilatation, and left atrial dilatation in our study.
Gender difference in echocardiographic abnormalities
among CKD patients has not been a consistent finding.16
We also evaluated whether the underlying etiology of
CKD has any effect on the prevalence of assessed echo-
cardiographic indexes. Diabetes mellitus and hypertension,
as two well-known traditional cardiovascular risk factors,
were associated with LVH, systolic, and diastolic dysfunc-
tions in univariate analysis. In a previous study,8 diabetes
mellitus and hypertension have also been shown to corre-
late with these echocardiographic abnormalities; however,
in multivariate analysis this association was not confirmed,
which is consistent with the results of Grossman et al’s17
study.
We found an association between a longer duration of
dialysis and LVH. Although many studies have shown an
increase in the prevalence of LVH in CKD patients over
time,18 studies showing that regression of this echocardio-
graphic abnormality in CKD patients is possible also exist.19
This can be explained by the different types of in-
terventions used in this population and different strategies
adopted in managing the risk factors affecting the pro-
gression of this condition.
LV end diastolic dilation, left atrial enlargement, and
diastolic dysfunction were associated with a longer dura-
tion of dialysis in this study. This can be explained by the
fact that many cardiac structural and functional abnor-
malities progress over time in this population even after
initiation of renal replacement therapy, as shown in pre-
vious studies.8,15,18,20,21
In this study, we also evaluated the association between
some uremia-related cardiovascular risk factors, such as
serum albumin, anemia, total serum calcium and
Table 4 Linear regression of the association between quantitative clinical factor and echocardiographic abnormalities in
hemodialysis patients.
Variables Left ventricular end
diastolic diameter
Left atrial diameter Systolic dysfunction
B Beta p B Beta p B Beta p
Sex
Male d d d d d d d d d
Female 4.2 0.277 0.004 2.1 0.14 0.001 0.5 0.035 0.329
Age 0.05 0.065 0.007 0.07 0.128 0.001 0.03 0.060 0.092
Duration of CKD diagnosis (mo) 1.4 0.138 0.001 0.03 0.091 0.011 0.02 0.067 0.069
Duration of dialysis (mo) 0.02 0.057 0.056 1.4 0.138 0.001 1.4 0.134 0.001
Type of dialysis
Peritoneal dialysis d d d d d d d d d
Hemodialysis 8.1 0.057 0.087 8.8 0.061 0.077 6.3 0.042 0.238
Hemoglobin 0.31 0.097 0.003 0.2 0.08 0.021 0.1 0.024 0.496
Albumin 0.1 0.009 0.271 0.8 0.07 0.049 0.3 0.028 0.438
Calcium 0.4 0.065 0.046 0.4 0.06 0.049 0.1 0.021 0.559
Phosphate 0.1 0.037 0.252 0.8 0.024 0.492 0.2 0.054 0.130
CKD Z chronic kidney disease.
72 M. Pakfetrat et al.phosphate, and echocardiographic abnormalities. The he-
moglobin level was associated with LVH, LV end diastolic
diameter, and left atria dimension. This association is in
agreement with the results of many previous studies,22
which has introduced anemia as one of the correctable
factors in the development and progression of different
echocardiographic abnormalities. Anemia induces LV dila-
tion and compensatory LV hypertrophy, and is a risk factor
for de novo heart failure and earlier death.23 Each g/dL fall
in hemoglobin from the reference value was associated
with a 10 g/m2 rise in the LV mass index.15 Our finding
showed that each 1 mg/dL decrease in hemoglobin level
was associated with increases in LV end diastolic dimension
by 0.3 mm and left atrial dimension by 0.2 mm. Another
study revealed significant independent associations be-
tween the degree of LV dilation and anemia.24 Some studies
reported that correction of anemia with erythropoietin
failed to induce regression of concentric LV hypertrophy or
LV dilation, but it could prevent LV dilation in patients with
normal LV volumes.25
Previous studies have also declared that hypo-
albuminemia,9,26 as an index of malnutrition and hypocal-
cemia, and hyperphosphatemia, as a part of
hyperparathyroidism-related cardiomyopathy,27 affect the
prevalence of different echocardiographic abnormalities. In
this study; hypoalbuminemia was associated with left atrial
enlargement and LVH. We could not find any association be-
tween hyperphosphatemia and assessed echocardiography
indexes.
Calcium level was associated with LV end diastolic and
left atrial dimensions. Each 1 mg/dL decrease in calcium
level was associated with increases in LV end diastolic
dimension and left atrial dimension by 0.4 mm.
Hypoalbuminemia may result from malnutrition and
albuminuria in CKD. Data have shown that hypo-
albuminemia predicts the incident of heart failure auton-
omously in patients with end-stage renal disease28 and
elderly patients.29 It may contribute to the progression ofheart failure by favoring volume overload, myocardial
edema, exacerbation of oxidative stress and inflammation,
and diuretic resistance.27 Hypoalbuminemia provokes a low
plasma oncotic pressure, which facilitates the development
of pulmonary edema in patients without a critical increase
in pulmonary capillary hydrostatic pressures.30 Harnett
et al31 and Gupta et al32 showed that in patients with end-
stage renal disease, hypoalbuminemia predicted de novo
heart failure independently of age, serum hemoglobin,
blood pressure, LV systolic function, and hypertrophy.
Hypocalcemic dilated cardiomyopathy is a rare cause of
heart failure in adults, and most studies on this topic were
conducted in pediatric groups.33 Hypocalcemia related with
cardiomyopathy in renal failure has rarely been reported in
the literature.34 Common reports were in idiopathic hypo-
parathyroidism35 or after parathyriodectomy36 in adults.
Hypocalcemia reduces myocardial contractility and plays a
central role in muscle contraction. Calcium ion is required
for the depolarization/repolarization phases of the cardiac
cycle via the slow calcium channels. It is also important for
the activation of actin so that myosin can form cross-
bridges to cause contraction. Hypocalcemia can delay the
conduction of cardiac impulse and weaken contractility. In
the majority of reports, correction of hypocalcemia was
associated with the resolution of congestive heart failure
and improvement of LV geometry; systolic function
improved completely. Finally, our results show that pa-
tients on PD had a lower prevalence of left atrial enlarge-
ment and LV end diastolic dilation. We could not find any
similar association in previous studies.
One limitation of this study is its retrospective cross-
sectional design, and our results should be interpreted in
the context of the results of previous and future clinical
trials. Factors that had been described to affect the prev-
alence of echocardiographic abnormalities in CKD patients
were unavailable to us. Some important ones are smoking
history, results of blood pressure monitoring, inflammatory
indices such as reactive protein (CRP) and parathyroid
Echocardiography findings in dialysis patients 73hormone (PTH) level, which were missing in our database.
Introduction of newer techniques in echocardiographic
assessment of patients such as three-dimensional echo-
cardiography and tissue Doppler velocity imaging tech-
niques may enrich our results further.
In conclusion, different echocardiographic abnormalities
in the left side of the heart are prevalent among CKD pa-
tients. The most common finding is LVH. Traditional risk
factors, such as age, diabetes mellitus, and hypertension,
and uremia-related risk factors, such as anemia and hypo-
albuminemia, are associated with an increase in the prev-
alence of these abnormalities.Acknowledgments
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